Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
Desmopressin acetate is a synthetic vasopressin analogue administered by the intranasal route. It is long-acting and well tolerated and may be the agent of choice for treating central diabetes insipidus.
D000281:Administration, Intranasal; D001127:Arginine Vasopressin / Q000627:therapeutic use*; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000188:drug therapy*; D003920:Diabetes Mellitus / Q000209:etiology; D004341:Drug Evaluation; D006801:Humans; D007668:Kidney / Q000187:drug effects
D001127:Arginine Vasopressin; D003894:Deamino Arginine Vasopressin